Evidence map›Paper›PMID 8163940›Full record

ArticleThe Journal of experimental medicine1994

YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes.

J P Ting, A Painter, N J Zeleznik-Le, G MacDonald, T M Moore, A Brown, B D Schwartz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J P TingDepartment of Microbiology-Immunology, University of North Carolina at Chapel Hill 27599-7295.
A Painter
N J Zeleznik-Le
G MacDonald
T M Moore
A Brown
B D Schwartz
University of North Carolina at Chapel Hill · US

Funding

ISOLATION OF CDNA'S FOR HLA CLASS II TRANSACTING FACTORSR01AI027430 · NIAID · WASHINGTON UNIVERSITY · PI SCHWARTZ, BENJAMIN D · 1989 to 1992
–
MOLECULAR CONTROL OF HLA-DR GENES IN T AND B LYMPHOCYTESR01CA048185 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI TING, JENNY P.Y. · 1988 to 1996
–
NCI NIH HHS CA 37172NCI NIH HHS R01 CA-48185NIAID NIH HHS R01 AI-27430
6 · The paper itself

Abstract

Interferon gamma (IFN-gamma) is the most potent inducer of class II major histocompatibility complex (MHC) genes. This induction is uniquely mediated by three DNA elements in the promoter region of class II MHC genes. One of these DNA elements, Y, contains an inverted CCAAT box. Previously, we have screened a lambda gt11 library for Y-binding proteins and identified the YB-1 gene. Here we provide evidence that YB-1 can repress the IFN-gamma induction of class II MHC promoter as well as the Invariant chain (Ii) gene which also contains a Y element in its promoter. This was demonstrated by cotransfecting a YB-1 expression vector with promoter-reporter gene constructs. As an alternate approach, an efficient transient transfection system was developed which resulted in a > 70% transfection efficiency. Transfection of YB-1 by this procedure resulted in the near abrogation of IFN-gamma induced HLA-DR antigen and mRNA expression. These findings show the functional suppression of class II MHC gene induction by the YB-1 protein.

Indexed as

Antigens, Differentiation, B-LymphocyteCCAAT-Enhancer-Binding ProteinsGene Expression RegulationGenes, MHC Class IIAnimalsBase SequenceCattleDNADNA-Binding ProteinsHistocompatibility Antigens Class IIHLA-DR AntigensInterferon-gammaMolecular Sequence DataNFI Transcription FactorsNuclear ProteinsPromoter Regions, GeneticAntigens, Differentiation, B-LymphocyteCCAAT-Enhancer-Binding ProteinsDNADNA-Binding ProteinsHistocompatibility Antigens Class IIHLA-DR AntigensInterferon-gammainvariant chainNFI Transcription FactorsNuclear ProteinsRNA, MessengerTranscription FactorsY-Box-Binding Protein 1YBX1 protein, human

Identifiers

PMID8163940
PMCPMC2191494
OpenAlexW2015208215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.